Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Contribution to Carbapenem Resistance and Fitness Cost of DcuS/DcuR, RcsC/RcsB, and YehU/YehT Two-Component Systems in CTX-M-15-Producing Escherichia coli.

Logre E, Denamur E, Mammeri H.

Microb Drug Resist. 2019 Oct 9. doi: 10.1089/mdr.2019.0027. [Epub ahead of print]

PMID:
31596659
2.

Epidemiology and Whole-Genome Analysis of NDM-1-Producing Klebsiella pneumoniae KP3771 from Tunisia.

Mansour W, Grami R, Jaidane N, Messaoudi A, Charfi K, Ben Romdhane L, Bel Haj Khalifa A, Khedher M, Boujaafar N, Bouallègue O, Mammeri H.

Microb Drug Resist. 2019 Jun;25(5):644-651. doi: 10.1089/mdr.2018.0204. Epub 2019 Jan 2.

PMID:
30614778
3.

Orogenital Transmission of Neisseria meningitidis Causing Acute Urethritis in Men Who Have Sex with Men.

Jannic A, Mammeri H, Larcher L, Descamps V, Tosini W, Phung B, Yazdanpanah Y, Bouscarat F.

Emerg Infect Dis. 2019 Jan;25(1):175-176. doi: 10.3201/eid2501.171102.

4.

Extended-spectrum β-lactamases and plasmid-mediated quinolone resistance in enterobacterial clinical isolates from neonates in Tunisia.

Charfi K, Grami R, Ben Jeddou A, Messaoudi A, Mani Y, Bouallegue O, Boujaafar N, Aouni M, Mammeri H, Mansour W.

Microb Pathog. 2017 Sep;110:184-188. doi: 10.1016/j.micpath.2017.06.030. Epub 2017 Jun 23.

PMID:
28648624
5.

KPC-3-producing ST167 Escherichia coli from mussels bought at a retail market in Tunisia.

Mani Y, Mansour W, Mammeri H, Denamur E, Saras E, Boujâafar N, Bouallègue O, Madec JY, Haenni M.

J Antimicrob Chemother. 2017 Aug 1;72(8):2403-2404. doi: 10.1093/jac/dkx124. No abstract available.

PMID:
28472479
6.

Structural Alteration of OmpR as a Source of Ertapenem Resistance in a CTX-M-15-Producing Escherichia coli O25b:H4 Sequence Type 131 Clinical Isolate.

Dupont H, Choinier P, Roche D, Adiba S, Sookdeb M, Branger C, Denamur E, Mammeri H.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e00014-17. doi: 10.1128/AAC.00014-17. Print 2017 May.

7.

First report of human infection due to Streptococcus devriesei.

Tammaro P, Richard N, Andre B, Andremont A, Mammeri H.

New Microbes New Infect. 2016 Nov 15;15:72-73. doi: 10.1016/j.nmni.2016.11.009. eCollection 2017 Jan.

8.

Mitral endocarditis due to Rothia aeria with cerebral haemorrhage and femoral mycotic aneurysms, first French description.

Collarino R, Vergeylen U, Emeraud C, Latournèrie G, Grall N, Mammeri H, Messika-Zeitoun D, Vallois D, Yazdanpanah Y, Lescure FX, Bleibtreu A.

New Microbes New Infect. 2016 Jun 11;13:40-2. doi: 10.1016/j.nmni.2016.06.004. eCollection 2016 Sep.

9.

Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations.

Dupont H, Gaillot O, Goetgheluck AS, Plassart C, Emond JP, Lecuru M, Gaillard N, Derdouri S, Lemaire B, Girard de Courtilles M, Cattoir V, Mammeri H.

Antimicrob Agents Chemother. 2015 Oct 19;60(1):215-21. doi: 10.1128/AAC.01559-15. Print 2016 Jan.

10.

Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to β-lactams in ICU patients: A pilot study.

Dupont H, Marciniak S, Zogheib E, Mammeri H, Friggeri A, Ammenouche N, Levrard M, Airapetian N, Tinturier F, Mahjoub Y.

Anaesth Crit Care Pain Med. 2015 Jun;34(3):141-4. doi: 10.1016/j.accpm.2015.02.004. Epub 2015 May 23.

PMID:
26004874
11.

Emergence of OXA-204 β-lactamase in Tunisia.

Charfi K, Mansour W, Khalifa AB, Mastouri M, Aouni M, Mammeri H.

Diagn Microbiol Infect Dis. 2015 Aug;82(4):314-7. doi: 10.1016/j.diagmicrobio.2015.04.003. Epub 2015 Apr 24.

PMID:
26001616
12.

Characterization of a novel AmpC β-lactamase produced by a carbapenem-resistant Cedecea davisae clinical isolate.

Ammenouche N, Dupont H, Mammeri H.

Antimicrob Agents Chemother. 2014 Nov;58(11):6942-5. doi: 10.1128/AAC.03237-14. Epub 2014 Aug 18.

13.

Use of avibactam to detect Ambler class A carbapenemases and OXA-48 β-lactamases in Enterobacteriaceae.

Porres-Osante N, de Champs C, Dupont H, Torres C, Mammeri H.

Diagn Microbiol Infect Dis. 2014 Jul;79(3):399-400. doi: 10.1016/j.diagmicrobio.2014.03.024. Epub 2014 Apr 12. No abstract available.

PMID:
24809860
14.

Avibactam activity against extended-spectrum AmpC β-lactamases.

Porres-Osante N, Dupont H, Torres C, Ammenouche N, de Champs C, Mammeri H.

J Antimicrob Chemother. 2014 Jun;69(6):1715-6. doi: 10.1093/jac/dku002. Epub 2014 Jan 26. No abstract available.

PMID:
24468864
15.

Comparison of Xpert MRSA/SA Nasal and MRSA/SA ELITe MGB assays for detection of the mecA gene with susceptibility testing methods for determination of methicillin resistance in Staphylococcus aureus isolates.

Belmekki M, Mammeri H, Hamdad F, Rousseau F, Canarelli B, Biendo M.

J Clin Microbiol. 2013 Oct;51(10):3183-91. doi: 10.1128/JCM.00860-13. Epub 2013 Jul 17.

16.

Contribution of asparagine 346 residue to the carbapenemase activity of CMY-2 β-lactamase.

Dahyot S, Broutin I, de Champs C, Guillon H, Mammeri H.

FEMS Microbiol Lett. 2013 Aug;345(2):147-53. doi: 10.1111/1574-6968.12199. Epub 2013 Jul 1.

17.

'Leptotrichia amnionii', a newly reported cause of early onset neonatal meningitis.

Decroix V, Goudjil S, Kongolo G, Mammeri H.

J Med Microbiol. 2013 May;62(Pt 5):785-8. doi: 10.1099/jmm.0.051870-0. Epub 2013 Feb 1.

PMID:
23378562
18.

Value of Xpert MRSA/SA blood culture assay on the Gene Xpert® Dx System for rapid detection of Staphylococcus aureus and coagulase-negative staphylococci in patients with staphylococcal bacteremia.

Biendo M, Mammeri H, Pluquet E, Guillon H, Rousseau F, Canarelli B, Belmekki M, Eb F.

Diagn Microbiol Infect Dis. 2013 Feb;75(2):139-43. doi: 10.1016/j.diagmicrobio.2012.11.005. Epub 2012 Dec 27.

PMID:
23273338
19.

Hydrolysis spectrum extension of CMY-2-like β-lactamases resulting from structural alteration in the Y-X-N loop.

Dahyot S, Mammeri H.

Antimicrob Agents Chemother. 2012 Mar;56(3):1151-6. doi: 10.1128/AAC.05630-11. Epub 2012 Jan 9.

20.

Emergence of ertapenem resistance in an Escherichia coli clinical isolate producing extended-spectrum beta-lactamase AmpC.

Guillon H, Tande D, Mammeri H.

Antimicrob Agents Chemother. 2011 Sep;55(9):4443-6. doi: 10.1128/AAC.01513-10. Epub 2011 Jul 11.

21.

Sensitive and specific phenotypic assay for metallo-beta-lactamase detection in Enterobacteria by use of a moxalactam disk supplemented with EDTA.

Pluquet E, Arlet G, Bingen E, Drieux L, Mammeri H.

J Clin Microbiol. 2011 Jul;49(7):2667-70. doi: 10.1128/JCM.00328-11. Epub 2011 May 4.

22.

Unusual acute endophthalmitis due to an as yet unclassified Acinetobacter gyllenbergii-like isolate.

Pluquet E, Brémond-Gignac D, Milazzo S, Mammeri H.

J Med Microbiol. 2011 Sep;60(Pt 9):1379-82. doi: 10.1099/jmm.0.026609-0. Epub 2011 Apr 1.

PMID:
21459914
23.

Phenotypic and biochemical comparison of the carbapenem-hydrolyzing activities of five plasmid-borne AmpC β-lactamases.

Mammeri H, Guillon H, Eb F, Nordmann P.

Antimicrob Agents Chemother. 2010 Nov;54(11):4556-60. doi: 10.1128/AAC.01762-09. Epub 2010 Aug 23.

24.

Characterization of CSP-1, a novel extended-spectrum beta-lactamase produced by a clinical isolate of Capnocytophaga sputigena.

Guillon H, Eb F, Mammeri H.

Antimicrob Agents Chemother. 2010 May;54(5):2231-4. doi: 10.1128/AAC.00791-09. Epub 2010 Mar 22.

25.

Role of the Ser-287-Asn replacement in the hydrolysis spectrum extension of AmpC beta-lactamases in Escherichia coli.

Mammeri H, Galleni M, Nordmann P.

Antimicrob Agents Chemother. 2009 Jan;53(1):323-6. doi: 10.1128/AAC.00608-08. Epub 2008 Nov 10.

26.

Potential evolution of hydrolysis spectrum for AmpC beta-lactamase of Escherichia coli.

Le Turnier S, Nordmann P, Eb F, Mammeri H.

J Antimicrob Chemother. 2009 Jan;63(1):216-8. doi: 10.1093/jac/dkn443. Epub 2008 Oct 27. No abstract available.

PMID:
18957396
27.

Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli.

Mammeri H, Nordmann P, Berkani A, Eb F.

FEMS Microbiol Lett. 2008 May;282(2):238-40. doi: 10.1111/j.1574-6968.2008.01126.x. Epub 2008 Mar 27.

28.

Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital.

Mammeri H, Eb F, Berkani A, Nordmann P.

J Antimicrob Chemother. 2008 Mar;61(3):498-503. doi: 10.1093/jac/dkm538. Epub 2008 Feb 4.

PMID:
18250231
30.

Extended-spectrum cephalosporinases: structure, detection and epidemiology.

Nordmann P, Mammeri H.

Future Microbiol. 2007 Jun;2(3):297-307. Review.

PMID:
17661704
31.

Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix.

Mammeri H, Poirel L, Nordmann P.

J Antimicrob Chemother. 2007 Sep;60(3):490-4. Epub 2007 Jun 22. Erratum in: J Antimicrob Chemother. 2008 Apr;61(4):971.

PMID:
17586561
32.

Expression of GDNF transgene in astrocytes improves cognitive deficits in aged rats.

Pertusa M, García-Matas S, Mammeri H, Adell A, Rodrigo T, Mallet J, Cristòfol R, Sarkis C, Sanfeliu C.

Neurobiol Aging. 2008 Sep;29(9):1366-79. Epub 2007 Mar 30.

PMID:
17399854
33.

Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo.

Philippe S, Sarkis C, Barkats M, Mammeri H, Ladroue C, Petit C, Mallet J, Serguera C.

Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17684-9. Epub 2006 Nov 9.

34.

Naturally occurring extended-spectrum cephalosporinases in Escherichia coli.

Mammeri H, Poirel L, Fortineau N, Nordmann P.

Antimicrob Agents Chemother. 2006 Jul;50(7):2573-6.

35.

Cloning and functional characterization of the ambler class C beta-lactamase of Yersinia ruckeri.

Mammeri H, Poirel L, Nazik H, Nordmann P.

FEMS Microbiol Lett. 2006 Apr;257(1):57-62.

36.

Bactericidal activity of fluoroquinolones against plasmid-mediated QnrA-producing Escherichia coli.

Mammeri H, Poirel L, Nordmann P.

Clin Microbiol Infect. 2005 Dec;11(12):1048-9. No abstract available.

37.

Origin of plasmid-mediated quinolone resistance determinant QnrA.

Poirel L, Rodriguez-Martinez JM, Mammeri H, Liard A, Nordmann P.

Antimicrob Agents Chemother. 2005 Aug;49(8):3523-5.

38.

Association of plasmid-mediated quinolone resistance with extended-spectrum beta-lactamase VEB-1.

Poirel L, Van De Loo M, Mammeri H, Nordmann P.

Antimicrob Agents Chemother. 2005 Jul;49(7):3091-4.

39.

Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe.

Mammeri H, Van De Loo M, Poirel L, Martinez-Martinez L, Nordmann P.

Antimicrob Agents Chemother. 2005 Jan;49(1):71-6.

40.

TEM-121, a novel complex mutant of TEM-type beta-lactamase from Enterobacter aerogenes.

Poirel L, Mammeri H, Nordmann P.

Antimicrob Agents Chemother. 2004 Dec;48(12):4528-31.

41.

AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins.

Mammeri H, Nazic H, Naas T, Poirel L, Léotard S, Nordmann P.

Antimicrob Agents Chemother. 2004 Oct;48(10):4050-3.

42.
43.
44.
46.

Catalytic and structural properties of IRT-21 beta-lactamase (TEM-77) from a co-amoxiclav-resistant Proteus mirabilis isolate.

Mammeri H, Gilly L, Laurans G, Vedel G, Eb F, Paul G.

FEMS Microbiol Lett. 2001 Dec 18;205(2):185-9. Erratum in: FEMS Microbiol Lett 2002 Mar 5;208(2):303-4.

47.

Supplemental Content

Loading ...
Support Center